BB Biotech AG (BBZA:XETRA) Annual Income Statement ()
BBZA:XETRA Quarterly Financials ()
Frequently Asked Questions About BB Biotech AG (BBZA:XETRA) Stock
BB Biotech AG's (BBZA:XETRA) last reported annual revenue was EUR -199567000.00.
BB Biotech AG's (BBZA:XETRA) annual revenue growth rate based on the revenue reported in the past 5 years is : 9.46%
BB Biotech AG's(BBZA:XETRA) is not profitable as of its last reported annual financials.
The net profit margin for BB Biotech AG's(BBZA:XETRA) from its laster reported year is 103.53%
The return on equity (ROE) for BB Biotech AG's(BBZA:XETRA) from its last reported annual financials is : -8.25%
The return on assets (ROA) for BB Biotech AG's(BBZA:XETRA) from its last reported annual financials is : -0.76%
The return on invested capital (ROIC) for BB Biotech AG's(BBZA:XETRA) from its last reported annual financials is : -8.25%
The Debt to Equity ratio for BB Biotech AG's(BBZA:XETRA) from its last reported annual financials is : 0.00%
The dividend yield for BB Biotech AG's(BBZA:XETRA) from its laster reported year is 4.75%
BB Biotech AG's(BBZA:XETRA) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BBZA:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
